Months of Screening. Done in Hours.
Tell AiDDA your protein target. It screens 1,000+ compounds, runs safety analysis, and delivers a ranked portfolio you can act on. No wet lab. No coding.
Three steps to your first campaign
Three steps. One afternoon. A complete drug candidate portfolio.
Describe your target
Name your protein and compound class in plain English. AiDDA researches the biology, finds binding sites, and curates a compound library.
AI screens & analyses
Virtual docking, safety profiling, and structure-activity analysis run in parallel. Multiple AI analysts cross-check findings.
Review your results
A prioritised portfolio with binding scores, safety flags, and scientific rationale — ready for your team or a grant submission.
Screen thousands of compounds in minutes
AiDDA takes your protein target and automatically identifies druggable binding sites, curates a relevant compound library from public databases, and runs GPU-accelerated virtual screening — delivering ranked hits faster than traditional methods by orders of magnitude.
- Automatic binding site detection
- Consensus scoring reduces false positives
- 1,000+ compounds screened per campaign
Filter out liabilities before they reach the bench
Every candidate is assessed for drug-likeness, predicted toxicity, metabolic stability, and off-target risks. You see the full safety picture alongside binding data — so you can deprioritise problematic compounds before spending time and budget on wet-lab validation.
- Toxicity and mutagenicity predictions
- Metabolic liability flagging
- Drug-likeness filtering (Lipinski and beyond)
- Off-target risk assessment
Safety Profile Preview
Reports your team can act on immediately
Every campaign concludes with a comprehensive research report — not just a spreadsheet of scores. You get prioritised candidates with scientific rationale, target intelligence, binding analysis, and recommended next experiments. Structured for team review, grant writing, or regulatory submission.
- Tiered candidate portfolio with rationale
- Target biology and pathway context
- Structure-activity relationship insights
- Recommended follow-up experiments
Campaign Report Contents
Key findings and top candidates
Biology, pathways, clinical context
Ranked portfolio with binding data
Per-compound risk profiles
Chemical feature insights
Prioritised next steps
Built for researchers at every stage
Whether you're an academic PI exploring a new target or a biotech scaling hit-to-lead, AiDDA adapts to your workflow.
Academic Labs
Explore new targets and compound classes without needing computational chemistry expertise. Generate publication-ready data and strengthen grant applications with comprehensive screening results.
Biotech Teams
Accelerate hit identification from months to hours. Run multiple campaigns in parallel across different targets and let your team focus on the science that matters — evaluating and validating promising candidates.
CROs & Service Labs
Offer virtual screening as a service with consistent, reproducible methodology. Every campaign is fully documented with audit trails — ready for client delivery or regulatory review.
Teams already shipping with AiDDA
“Cut our hit identification time from 3 months to 2 days. AiDDA gives our team the analytical depth we need, right when we need it.”
“The depth of the reports AiDDA produces is remarkable. Our researchers have more time to think and less time chasing down data.”
Pay for results, not access
Every plan is built around campaigns — a complete screening run with a research report you can act on. No seat fees. No API metering. You pay when we deliver.
Starter
For academic PIs, solo founders, and lean seed-stage startups
- 5 campaigns per month
- Cloud UI access
- Standard AI-assisted screening workflows
- Comprehensive research reports
- Email support
- $200 per additional campaign
Team
For Series A biotechs and active labs managing multiple targets
- 20 campaigns per month
- Collaborative workspaces
- Generative compound design
- Priority compute queue
- Priority email & Slack support
- $200 per additional campaign
Growth
For CROs and high-throughput screening operations ready to scale
- 50 campaigns per month
- API access for lab integration
- Custom AI agent workflows
- Dedicated Customer Success Manager
- SLA guarantees
- $200 per additional campaign
Frequently asked questions
Straight answers to common questions.
AiDDA works with any protein target for which structural data is available. Simply provide your target and AiDDA handles all preparation automatically, including binding site identification. You can also upload your own structural files if you have proprietary or unpublished data.
AiDDA uses a proprietary consensus scoring approach that combines complementary computational methods, significantly outperforming single-method workflows in benchmark studies. We provide benchmark data across multiple target classes so you can calibrate confidence in the results before committing to wet-lab validation.
Yes, AiDDA supports on-premises deployment for organisations with sensitive compound libraries or specific data residency requirements. Our enterprise tier includes full deployment support, security review, and custom integration with your existing infrastructure.
AiDDA comes pre-loaded with access to industry-standard databases covering millions of commercially available compounds. You can also upload your own proprietary libraries in standard chemical file formats, and AiDDA handles all preparation steps automatically.
AiDDA's AI analyses your campaign across multiple scientific dimensions simultaneously — target biology, binding potential, safety profile, and interaction quality. Rather than a rigid linear workflow, it reasons across all of these in parallel and synthesises the findings into a ranked shortlist with clear scientific rationale for every decision.
Every campaign produces a comprehensive research report covering: candidate rankings with supporting evidence, safety and drug-likeness assessments, binding interaction analysis, target biological context, and a full methodology section. Reports are structured for team review, regulatory submissions, or direct use in grant and publication writing.
We price on campaigns because that is the unit of value — a complete screening run with a full research report you can act on. Seat-based pricing penalises collaboration; API-call pricing is unpredictable and disconnected from outcomes. With campaign pricing, your cost scales with the work you actually do.
Stop waiting. Start screening.
Your first campaign takes 10 minutes to set up. Results land the same day.